| CEACAM1 |
CEACAM1, BGP, BGP1: Carcinoembryonic antigen-related cell adhesion molecule 1 pr |
PTPRJ |
PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor |
0.265 |
Evidence |
|
| PIK3CG |
PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.265 |
Evidence |
|
| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
TRIM25 |
TRIM25, EFP, RNF147, ZNF147: Tripartite motif-containing protein 25 |
0.265 |
Evidence |
|
| TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
CIB1 |
CIB1, CIB, KIP, PRKDCIP: Calcium and integrin-binding protein 1 |
0.265 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
CD80 |
CD80, CD28LG, CD28LG1, LAB7: T-lymphocyte activation antigen CD80 precursor |
0.265 |
Evidence |
|
| SMARCA5 |
SMARCA5, SNF2H, WCRF135: SWI/SNF-related matrix-associated actin-dependent regul |
TERF1 |
TERF1, PIN2, TRBF1, TRF, TRF1: Telomeric repeat-binding factor 1 |
0.265 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
PKN2 |
PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 |
0.265 |
Evidence |
|
| LPA |
LPA: Apolipoprotein(a) precursor |
F5 |
F5: Coagulation factor V precursor |
0.265 |
Evidence |
|
| TLN1 |
TLN1: Uncharacterized protein TLN1 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.265 |
Evidence |
|
| ELF1 |
ELF1: ETS-related transcription factor Elf-1 |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
0.265 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
CFH |
CFH, HF, HF1, HF2: Complement factor H precursor |
0.265 |
Evidence |
|
| PLD1 |
PLD1: Phospholipase D1 |
MAPK6 |
MAPK6, ERK3, PRKM6: Mitogen-activated protein kinase 6 |
0.265 |
Evidence |
|
| PVR |
PVR, PVS: Poliovirus receptor precursor |
HAVCR1 |
HAVCR1, TIM1, TIMD1: Hepatitis A virus cellular receptor 1 precursor |
0.265 |
Evidence |
|
| PIK3CD |
PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i |
APS |
SH2B2, APS: SH2B adapter protein 2 |
0.265 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
NEK7 |
NEK7: Serine/threonine-protein kinase Nek7 |
0.265 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
PKMYT1 |
PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito |
0.265 |
Evidence |
|
| H1FX |
H1FX: Histone H1x |
BAZ2A |
BAZ2A, KIAA0314, TIP5: Bromodomain adjacent to zinc finger domain protein 2A |
0.265 |
Evidence |
|
| NCOR1 |
NCOR1, KIAA1047: Nuclear receptor corepressor 1 |
TRIM28 |
TRIM28, KAP1, RNF96, TIF1B: Transcription intermediary factor 1-beta |
0.265 |
Evidence |
|
| NDP |
NDP: Norrin precursor |
CNTN2 |
CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor |
0.265 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
HSPG2 |
HSPG2: Basement membrane-specific heparan sulfate proteoglycan core protein prec |
0.265 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
0.265 |
Evidence |
|
| IGF2 |
IGF2, PP1446: Insulin-like growth factor II precursor |
C8B |
C8B: Complement component C8 beta chain precursor |
0.265 |
Evidence |
|
| RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.265 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
SRPK2 |
SRPK2: Serine/threonine-protein kinase SRPK2 |
0.265 |
Evidence |
|
| IKBKB |
IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta |
HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
0.265 |
Evidence |
|
- 
- 
-